COVID-19 vaccine side effects among nursing home residents and staff.
作者信息
Bhatnagar Sankalp, Jones Karen, Montoya Ana
机构信息
Department of Internal Medicine, Division of Geriatric and Palliative Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
Post-Acute Care Services, University of Michigan Medical Group, Ann Arbor, Michigan, USA.
出版信息
J Med Virol. 2022 Aug;94(8):3491-3493. doi: 10.1002/jmv.27756. Epub 2022 Apr 12.
Abstract
摘要
相似文献
1
COVID-19 vaccine side effects among nursing home residents and staff.养老院居民和工作人员中的新冠病毒疫苗副作用
J Med Virol. 2022 Aug;94(8):3491-3493. doi: 10.1002/jmv.27756. Epub 2022 Apr 12.
2
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
3
Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.BNT162b2 疫苗接种与 SARS-CoV-2 感染及与 covid-19 相关的住院和死亡的关联：在加泰罗尼亚的养老院和医护人员中的前瞻性队列研究。
BMJ. 2021 Aug 18;374:n1868. doi: 10.1136/bmj.n1868.
4
SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.养老院居民接种二价 COVID-19 疫苗后对原始 SARS-CoV-2 株和奥密克戎 BA.1 和 BA.4/BA.5 变异株的 SARS-CoV-2 抗体反应 - 俄亥俄州和罗得岛，2022 年 9 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):100-106. doi: 10.15585/mmwr.mm7204a4.
5
Protective effects of prior third dose mRNA vaccination in rural nursing home residents during SARS-CoV-2 outbreaks.在 SARS-CoV-2 疫情期间，第三剂 mRNA 疫苗接种对农村养老院居民的保护作用。
J Am Geriatr Soc. 2022 Nov;70(11):3245-3249. doi: 10.1111/jgs.17996. Epub 2022 Aug 8.
6
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine.接受完整剂量的Comirnaty® COVID-19疫苗后，疗养院居民中SARS-CoV-2免疫反应的演变。
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.10.026. Epub 2021 Nov 2.
7
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.奥密克戎变异株广泛传播期间，养老院居民接种 COVID-19 追加初级或加强疫苗剂量对预防 SARS-CoV-2 感染的效果-美国，2022 年 2 月 14 日-3 月 27 日。
MMWR Morb Mortal Wkly Rep. 2022 May 6;71(18):633-637. doi: 10.15585/mmwr.mm7118a4.
8
Effectiveness of COVID-19 bivalent vaccination against SARS-CoV-2 infection among residents of US nursing homes, November 2022 - March 2023.2022 年 11 月至 2023 年 3 月，美国养老院居民中 COVID-19 二价疫苗接种对 SARS-CoV-2 感染的有效性。
Vaccine. 2024 Oct 24;42(24):126112. doi: 10.1016/j.vaccine.2024.07.013. Epub 2024 Jul 16.
9
Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Residents of US Nursing Homes Before and During the Delta Variant Predominance, December 2020-November 2021.2020 年 12 月-2021 年 11 月，美国养老院居民在德尔塔变异株流行前后，接种 2019 冠状病毒病（COVID-19）疫苗对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染的效果。
Clin Infect Dis. 2022 Oct 3;75(Suppl 2):S147-S154. doi: 10.1093/cid/ciac562.
10
Declining Prevalence of SARS-CoV-2 Antibodies among Vaccinated Nursing Home Residents and Staff Six Months after the Primary BNT162b2 Vaccination Campaign in Belgium: A Prospective Cohort Study.比利时首次 BNT162b2 疫苗接种活动 6 个月后，接种疫苗的养老院居民和工作人员中 SARS-CoV-2 抗体流行率下降：一项前瞻性队列研究。
Viruses. 2022 Oct 26;14(11):2361. doi: 10.3390/v14112361.
引用本文的文献
1
Efficacy of cardiopulmonary rehabilitation nursing in enhancing pulmonary function, sleep quality, and living ability in COVID-19 patients.心肺康复护理对提高新型冠状病毒肺炎患者肺功能、睡眠质量及生活能力的效果
Am J Transl Res. 2024 Apr 15;16(4):1468-1476. doi: 10.62347/KYKR6707. eCollection 2024.
本文引用的文献
1
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
2
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
3
Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.COVID-19 疫苗在预防≥65 岁成年人住院方面的有效性 - COVID-NET，13 个州，2021 年 2 月至 4 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1088-1093. doi: 10.15585/mmwr.mm7032e3.
4
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.mRNA SARS-CoV-2 疫苗接种后美国养老院居民的不良事件。
Vaccine. 2021 Jun 29;39(29):3844-3851. doi: 10.1016/j.vaccine.2021.05.088. Epub 2021 May 28.
5
Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.COVID-19 mRNA-1273 疫苗的非危及生命的不良反应：一项针对医护人员的随机、横断面研究，详细报告了自报告症状。
J Med Virol. 2021 Jul;93(7):4420-4429. doi: 10.1002/jmv.26996. Epub 2021 May 5.
6
Management of anaphylaxis due to COVID-19 vaccines in the elderly.老年人因 COVID-19 疫苗而产生的过敏反应的管理。
Allergy. 2021 Oct;76(10):2952-2964. doi: 10.1111/all.14838.
7
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
8
Willingness of Long-Term Care Staff to Receive a COVID-19 Vaccine: A Single State Survey.长期护理人员接种 COVID-19 疫苗的意愿：一项单一州调查。
J Am Geriatr Soc. 2021 Mar;69(3):593-599. doi: 10.1111/jgs.17022. Epub 2021 Jan 13.
9
Efficacy and safety of COVID-19 vaccines in older people.新型冠状病毒疫苗在老年人中的疗效和安全性。
Age Ageing. 2021 Feb 26;50(2):279-283. doi: 10.1093/ageing/afaa274.
Zotero 插件